Skip to content

Clinical trials

Phase 2 Pleural Effusion, Malignant trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pleural Effusion, Malignant Phase: Phase 2 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20053
20062
20072
20081
20091
20101
20151

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
H. Lee Moffitt Cancer Center and Research Institute2
M.D. Anderson Cancer Center2
University of Washington2
Abramson Cancer Center at Penn Medicine1
Canadian Cancer Trials Group1
Eli Lilly and Company1
Genzyme, a Sanofi Company1
Peter Bushunow MD1
University of Chicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pleural Effusion, Malignant15
Carcinoma, Non-Small-Cell Lung9
Carcinoma, Ovarian Epithelial3
Fallopian Tube Neoplasms3
Neoplasm Metastasis3
Adenocarcinoma of Lung2
Lung Neoplasms2
Ovarian Neoplasms2
Adenocarcinoma, Bronchiolo-Alveolar1
Brenner Tumor1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.